CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Reflux Band® Upper Esophageal Sphincter (UES) Assist Deviceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03619811
NCT03619811N/ACompleted
CompareCT.gov

Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease

University of California, San Diego·interventional·Posted Aug 8, 2018·Updated Sep 20, 2021

In Brief

A clinical study evaluating Reflux Band® Upper Esophageal Sphincter (UES) Assist Device for Gastroesophageal Reflux and Laryngopharyngeal Reflux. Completed, enrolled 43 participants across 1 site.

Detailed Summary

This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux, Laryngopharyngeal Reflux
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 8, 2018
Enrollment StartJul 13, 2018
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.9 years ago

Interventions

Reflux Band® Upper Esophageal Sphincter (UES) Assist Deviceother

UES augmentation via the UES assist device is effective in true Reflux associated laryngeal symptoms. In our first pilot trial with the UES assist device, patients had significant symptom reduction following 2 weeks of UES assist device use. Based on our preliminary work, we theorize that the UES assist device is effective in Reflux associated laryngeal symptoms.